Non-Small Cell Lung Cancer Panel
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Wallace Akerley, MD |
Genentech, Inc.; |
Genentech, Inc. |
None |
None |
9/28/2009 |
Gerold Bepler, MD, PhD |
Genzyme Corporation |
Eli Lilly and Company; |
Genzyme Corporation |
Eli Lilly and Company; |
12/15/2008 |
Matthew G. Blum, MD |
None |
None |
None |
None |
7/17/2009 |
Andrew Chang, MD |
None |
None |
None |
None |
9/28/2009 |
Richard T. Cheney, MD |
None |
None |
None |
None |
12/15/2008 |
Lucian R. Chirieac, MD |
None |
None |
None |
None |
10/2/2009 |
Thomas A. D'Amico, MD |
None |
Covidien AG; |
None |
None |
7/1/2009 |
Todd L. Demmy, MD |
None |
Covidien AG |
None |
None |
7/13/2009 |
David S. Ettinger, MD |
None |
AstraZeneca Pharmaceuticals LP; |
None |
None |
7/6/2009 |
Lauren Gallagher, PhD |
None |
None |
None |
None |
8/28/2009 |
Ramaswamy Govindan, MD |
None |
Bristol-Myers Squibb Company; |
None |
None |
10/14/2009 |
Frederic W. Grannis, MD |
GlaxoSmithKline |
Steven Phillips (sphillips@lpklaw.com) |
None |
Medtronic, Inc. |
7/14/2009 |
Kristina M Gregory, RN, MSN, OCN |
None |
None |
None |
None |
8/21/2009 |
Miranda Hughes, PhD |
None |
None |
Myriad Genetic Laboratories, Inc.; |
None |
7/21/2009 |
Thierry M. Jahan, MD |
Eli Lilly and Company; |
Poniard Pharmaceuticals |
None |
None |
12/15/2008 |
Mohammad Jahanzeb, MD, FACP |
Genentech, Inc.; |
Abraxis Bioscience, Inc.; |
None |
None |
10/29/2009 |
David H. Johnson, MD |
Merck & Co., Inc.; |
None |
None |
None |
9/29/2009 |
Anne Kessinger, MD |
Pharmacyclics; |
None |
None |
None |
5/19/2009 |
Ritsuko Komaki, MD |
Pfizer Inc. |
None |
None |
None |
10/2/2009 |
Feng-Ming (Spring) Kong, MD, PhD, MPH |
None |
None |
None |
None |
8/17/2009 |
Mark G. Kris, MD |
None |
AstraZeneca Pharmaceuticals LP; |
None |
None |
10/2/2009 |
Quynh-Thu Le, MD |
Amgen Inc.; |
None |
None |
None |
7/2/2009 |
Inga T. Lennes, MD |
None |
None |
None |
None |
7/1/2009 |
Renato Martins, MD, MPH |
Amgen Inc.; |
Eli Lilly and Company; |
None |
None |
9/30/2009 |
Joan S McClure, MS |
None |
None |
None |
None |
9/28/2009 |
Janis O'Malley, MD |
Pending |
||||
Raymond U. Osarogiagbon, MD, FACP |
Bristol-Myers Squibb Company; |
Genentech, Inc.; |
None |
None |
10/1/2009 |
Gregory A. Otterson, MD |
Abraxis Oncology; |
Eli Lilly and Company; |
None |
None |
10/1/2009 |
Jyoti D. Patel, MD |
Eli Lilly and Company; |
Eli Lilly and Company; |
None |
None |
7/6/2009 |
Katherine M Pisters, MD |
None |
None |
None |
None |
7/1/2009 |
Karen Reckamp, MD, MS |
Amgen Inc.; |
Amgen Inc.; |
None |
None |
7/1/2009 |
Eric Rohren, MD, PhD |
None |
None |
None |
None |
7/1/2009 |
George R. Simon, MD, FACP, FCCP |
None |
None |
None |
None |
7/10/2009 |
Scott Swanson, MD |
None |
Covidien AG; |
None |
None |
8/26/2009 |
Douglas E. Wood, MD |
None |
None |
None |
None |
9/28/2009 |
Stephen C. Yang, MD |
None |
None |
None |
None |
12/15/2008 |